Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

Grace Callagy, Paul D.P. Pharoah, Sarah E. Pinder, Forrest D. Hsu, Torsten O. Nielsen, Joseph Ragaz, Ian O. Ellis, David G. Huntsman, Carlos Caldas

Clinical Cancer Research · 2006 · 237 citations · 48 references

Abstract

Bcl-2 is an independent predictor of breast cancer outcome and seems to be useful as a prognostic adjunct to the NPI, particularly in the first 5 years after diagnosis.

References

48